Jonas Brinck

Om mig

I started medical school at Uppsala university 1993 and completed my studies in 2002. During this period, I was also a PhD student and defended my thesis in 2000 at the of Department of Medical Biochemistry and Microbiology, Uppsala university. I have worked clinically at Karolinska university hospital since 2004 at the Medical unit Endocrinology in parallel to my research at the Dept of Medicine Huddinge (MEDH7), KI. I have done a post-doctorial fellowship at Geneva university hospital 2011-2015 in prof. Richard W James group studying lipoprotein functionality in cellbased models.

I am today a senior consultant in endocrinology and diabetology. I am a key-opinion-leader in the field of dyslipidaemia in Sweden and I am an author/contributor to regional clinical guidelines.

Forskningsbeskrivning

My research focuses on epidemiological and experimental aspects of hereditary dyslipidaemias. I am a team leader in the newly formed Cardiometabolic unit at MEDH7 department under Professor Paolo Parini. In my research team is KI-associated researcher Karin Littmann, PhD student Tigist Wodaje, research nurse Viveca Åberg and medical student Simon Sjuls. We also perform clinical trials in phase II-III in the field of dyslipidaemia and lipid lowering therapy.

We study hereditary dyslipidaemias including Familial hypercholesterolemia, elevated Lipoprotein(a) and Familial Chylomicronemia Syndrome and their effects on atherosclerotic cardiovascular disease, metabolic disease, and diabetes. In our clinical and experimental studies, we study their effects on coronary blood flow capacity, endothel function and calcified aortic valve disease biomarkers. In our epidemiological research, we are working with regional and national cohorts to study their impact on various forms of cardiovascular disease, development of cardiometabolic and liver disease.